Azoulay, Elie http://orcid.org/0000-0002-8162-1508
Forel, Jean-Marie
Vinatier, Isabelle
Truillet, Romain
Renault, Anne
Valade, Sandrine
Jaber, Samir
Durand-Gasselin, Jacques
Schwebel, Carole
Georges, Hughes
Merceron, Sybille
Cariou, Alain
Moussa, Myriam
Hraiech, Sami
Argaud, Laurent
Leone, Marc
Curtis, J. Randall
Kentish-Barnes, Nancy
Jouve, Elisabeth
Papazian, Laurent
Funding for this research was provided by:
Ministère de la Santé France (APHM MRS 2014 FAMIREA)
Article History
Received: 26 April 2018
Accepted: 17 October 2018
First Online: 21 October 2018
Compliance with ethical standards
:
: Dr. Azoulay reports personal fees and other from Gilead, personal fees from Astellas, personal fees from Baxter, personal fees from Alexion, personal fees from Ablynx, outside the submitted work. Other authors declare no conflict of interest.
: The study protocol was approved by the appropriate ethics committee (IFR 48 #13-004, Marseille) and French health authorities (CNIL DR-2013-497; CCTIRS 13.332). The trial was registered on ClinicalTrials.gov (NCT02410538). Informed consent was obtained from all participants.